Breaking News, Collaborations & Alliances

MS Pharma Group, Hetero Group Partner to Localize Biosimilars in MENA Region

Partnership marks Hetero’s first localized biopharma venture in Algeria.

Author Image

By: Charlie Sternberg

Associate Editor

MS Pharma Group, a regional pharmaceutical company in the MENA region, has signed a strategic partnership agreement with Hetero Group, a global pharmaceutical company, to localize five established biosimilars across key therapeutic areas, including oncology, immunology and hematology. The exclusive agreement will be implemented through El Kendi, MS Pharma Group’s affiliate in Algeria, and Hetero Biopharma, a subsidiary of Hetero Group. This marks Hetero’s first local partnership i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters